TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 43 filers reported holding TERNS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,964,641 | -42.5% | 788,115 | +0.1% | 0.00% | -100.0% |
| Q2 2023 | $6,890,721 | +91.0% | 787,511 | +158.4% | 0.00% | – |
| Q1 2023 | $3,607,837 | +199448.5% | 304,716 | +71.5% | 0.00% | – |
| Q4 2022 | $1,808 | -99.8% | 177,648 | +5.2% | 0.00% | – |
| Q3 2022 | $994,000 | +407.1% | 168,848 | +112.9% | 0.00% | – |
| Q2 2022 | $196,000 | -63.2% | 79,324 | -55.8% | 0.00% | – |
| Q1 2022 | $532,000 | -58.4% | 179,311 | -0.9% | 0.00% | – |
| Q4 2021 | $1,279,000 | -36.5% | 180,935 | -6.4% | 0.00% | – |
| Q3 2021 | $2,014,000 | +14.8% | 193,336 | +35.1% | 0.00% | – |
| Q2 2021 | $1,754,000 | -38.8% | 143,069 | +9.8% | 0.00% | – |
| Q1 2021 | $2,865,000 | – | 130,263 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 6,657,992 | $33,489,700 | 3.67% |
| ACUTA CAPITAL PARTNERS, LLC | 555,260 | $2,792,958 | 1.87% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,041,910 | $30,390,807 | 1.64% |
| VR Adviser, LLC | 3,092,273 | $15,554,133 | 1.64% |
| Fairmount Funds Management LLC | 2,040,000 | $10,261,200 | 1.24% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $3,592,854 | 1.20% |
| Deep Track Capital, LP | 6,000,000 | $30,180,000 | 1.16% |
| Orbimed Advisors | 7,619,135 | $38,324,249 | 0.81% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 500,000 | $2,515,000 | 0.76% |
| GREAT POINT PARTNERS LLC | 645,899 | $3,248,872 | 0.59% |